Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

BPA and risk assessment

Publikation: Bidrag til tidsskriftLetterForskningpeer review

Harvard

Calafat, AM, Koch, HM, Andra, SS, Antignac, JP, Castaño, A, Choi, K, Covaci, A, Dekant, W, Doerge, DR, Frederiksen, H, Göen, T, Kolossa-Gehring, M, Leblanc, A, Mueller, JF, Nakayama, SF, Nassif, J, St-Amand, A, Völkel, W, Wolff, MS & additional coauthors 2020, 'BPA and risk assessment', The Lancet Diabetes and Endocrinology, bind 8, nr. 4, s. 269-270. https://doi.org/10.1016/S2213-8587(20)30070-X

APA

Calafat, A. M., Koch, H. M., Andra, S. S., Antignac, J. P., Castaño, A., Choi, K., Covaci, A., Dekant, W., Doerge, D. R., Frederiksen, H., Göen, T., Kolossa-Gehring, M., Leblanc, A., Mueller, J. F., Nakayama, S. F., Nassif, J., St-Amand, A., Völkel, W., Wolff, M. S., & additional coauthors (2020). BPA and risk assessment. The Lancet Diabetes and Endocrinology, 8(4), 269-270. https://doi.org/10.1016/S2213-8587(20)30070-X

CBE

Calafat AM, Koch HM, Andra SS, Antignac JP, Castaño A, Choi K, Covaci A, Dekant W, Doerge DR, Frederiksen H, Göen T, Kolossa-Gehring M, Leblanc A, Mueller JF, Nakayama SF, Nassif J, St-Amand A, Völkel W, Wolff MS, additional coauthors. 2020. BPA and risk assessment. The Lancet Diabetes and Endocrinology. 8(4):269-270. https://doi.org/10.1016/S2213-8587(20)30070-X

MLA

Vancouver

Calafat AM, Koch HM, Andra SS, Antignac JP, Castaño A, Choi K o.a. BPA and risk assessment. The Lancet Diabetes and Endocrinology. 2020 apr 1;8(4):269-270. https://doi.org/10.1016/S2213-8587(20)30070-X

Author

Calafat, Antonia M. ; Koch, Holger M. ; Andra, S. S. ; Antignac, J. P. ; Castaño, A. ; Choi, K. ; Covaci, A. ; Dekant, W. ; Doerge, D. R. ; Frederiksen, H. ; Göen, T. ; Kolossa-Gehring, M. ; Leblanc, A. ; Mueller, J. F. ; Nakayama, S. F. ; Nassif, J. ; St-Amand, A. ; Völkel, W. ; Wolff, M. S. ; additional coauthors. / BPA and risk assessment. I: The Lancet Diabetes and Endocrinology. 2020 ; Bind 8, Nr. 4. s. 269-270.

Bibtex

@article{c79c9129944148ab8ef0872a70e47c17,
title = "BPA and risk assessment",
keywords = "Benzhydryl Compounds, Risk Assessment",
author = "Calafat, {Antonia M.} and Koch, {Holger M.} and Andra, {S. S.} and Antignac, {J. P.} and A. Casta{\~n}o and K. Choi and A. Covaci and W. Dekant and Doerge, {D. R.} and H. Frederiksen and T. G{\"o}en and M. Kolossa-Gehring and A. Leblanc and Mueller, {J. F.} and Nakayama, {S. F.} and J. Nassif and A. St-Amand and W. V{\"o}lkel and Wolff, {M. S.} and {additional coauthors}",
year = "2020",
month = apr,
day = "1",
doi = "10.1016/S2213-8587(20)30070-X",
language = "English",
volume = "8",
pages = "269--270",
journal = "The Lancet Diabetes and Endocrinology",
issn = "2213-8587",
publisher = "London The Lancet, Diabetes & Endocrinology, 2013",
number = "4",

}

RIS

TY - JOUR

T1 - BPA and risk assessment

AU - Calafat, Antonia M.

AU - Koch, Holger M.

AU - Andra, S. S.

AU - Antignac, J. P.

AU - Castaño, A.

AU - Choi, K.

AU - Covaci, A.

AU - Dekant, W.

AU - Doerge, D. R.

AU - Frederiksen, H.

AU - Göen, T.

AU - Kolossa-Gehring, M.

AU - Leblanc, A.

AU - Mueller, J. F.

AU - Nakayama, S. F.

AU - Nassif, J.

AU - St-Amand, A.

AU - Völkel, W.

AU - Wolff, M. S.

AU - additional coauthors

PY - 2020/4/1

Y1 - 2020/4/1

KW - Benzhydryl Compounds

KW - Risk Assessment

UR - http://www.scopus.com/inward/record.url?scp=85081691332&partnerID=8YFLogxK

U2 - 10.1016/S2213-8587(20)30070-X

DO - 10.1016/S2213-8587(20)30070-X

M3 - Letter

C2 - 32197109

AN - SCOPUS:85081691332

VL - 8

SP - 269

EP - 270

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

SN - 2213-8587

IS - 4

ER -

ID: 59732495